As the demand for information outside of approved labeling continues to rise, the FDA has been called by the industry to provide guidance that governs off-label communications. The regulatory landscape that monitors this space is often blamed for limiting the amount of information received by patients and restricting their ability to make well-informed decisions.
Given the public health issues at stake and the public interest involved, it is
imperative that this event details the importance of the timely communication of truthful scientific information that currently challenges pharmaceutical, biotech, and medical device professionals. The 2018 Off-Label Regulatory Compliance Congress also explores the ever-changing regulatory landscape and explains how professionals can work with officials to ensure that promotional practices remain compliant and expedite the transmission of relevant scientific information to advance public health.
For information on speaking opportunities at this event, please contact Bianca Dux bdux@exlevents.com.
For information on sponsorship and exhibition opportunities, please contact Jon Mercado, Business Development Manager, at 917-932-0434 or at
jon.mercado@exlevents.com.
